ArticleThe oncologist2025

Precision medicine: an intrahepatic cholangiocarcinoma with a novel RBPMS-MET fusion sensitive to crizotinib.

Wei Wan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.